ALDR - Alder Biopharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ALDR (1423824)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
40 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S35+0-1-10-24

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-11-13
ALDRLitton Mark JamesChief Business OfficerS - Sale+OE$10.80-16,519177,932-8%-$178,486
D
2017-10-16
ALDRLitton Mark JamesChief Business OfficerS - Sale+OE$12.33-16,520177,932-8%-$203,703
2017-07-18
ALDRYarno Wendy LDirP - Purchase$10.00+5,0005,000New+$50,000
2017-07-18
ALDRDow Stephen MDirP - Purchase$10.00+25,000307,190+9%+$250,000
D
2017-06-20
ALDRSmith Jeffrey T LSVP Translational MedicineS - Sale+OE$20.00-585831-41%-$11,700
D
2017-02-09
ALDRSchatzman Randall CPres, CEOS - Sale+OE$25.03-30,000115,172-21%-$750,7560-3-5
D
2017-01-18
ALDRLitton Mark JamesChief Business OfficerS - Sale+OE$23.10-1,498177,932-1%-$34,599-4-5+11
DM
2017-01-05
ALDRLitton Mark JamesChief Business OfficerS - Sale+OE$23.01-9,516177,932-5%-$218,9920-4+4
D
2016-12-01
ALDRSmith Jeffrey T LSVP Translational MedicineS - Sale+OE$22.78-3,000831-78%-$68,328+1-5-4
D
2016-12-01
ALDRLatham John AChief Scientific OfficerS - Sale+OE$22.78-3,636242,403-1%-$82,812+1-5-4
D
2016-11-09
ALDRLatham John AChief Scientific OfficerS - Sale+OE$30.18-10,000242,200-4%-$301,839-3-17-37
D
2016-11-07
ALDRSchatzman Randall CPres, CEOS - Sale+OE$25.16-10,000114,768-8%-$251,605+3+14-31-41
D
2016-11-01
ALDRSmith Jeffrey T LSVP Translational MedicineS - Sale+OE$24.34-3,0000-100%-$73,032+8+30+2-7
2016-10-17
ALDRLitton Mark JamesChief Business OfficerS - Sale$27.50-6,000125,567-5%-$164,998+70+5-26
D
2016-10-03
ALDRSmith Jeffrey T LSVP Translational MedicineS - Sale+OE$31.14-3,0000-100%-$93,415-4-4-25-39
D
2016-10-03
ALDRSchatzman Randall CPres, CEOS - Sale+OE$31.15-8,181114,768-7%-$254,811-4-4-25-39
D
2016-10-03
ALDRLatham John AChief Scientific OfficerS - Sale+OE$31.32-10,000242,200-4%-$313,152-4-4-25-39
D
2016-09-01
ALDRLatham John AChief Scientific OfficerS - Sale+OE$32.49-10,000242,200-4%-$324,949+1-1-2-32
D
2016-09-01
ALDRSchatzman Randall CPres, CEOS - Sale+OE$32.48-10,000114,768-8%-$324,820+1-1-2-32
D
2016-09-01
ALDRSmith Jeffrey T LSVP Translational MedicineS - Sale+OE$32.49-3,0000-100%-$97,483+1-1-2-32
D
2016-08-15
ALDRSmith Jeffrey T LSVP Translational MedicineS - Sale+OE$31.17-3,0000-100%-$93,512+1+10+7-20
D
2016-08-01
ALDRSchatzman Randall CPres, CEOS - Sale+OE$31.15-10,000229,552-4%-$311,513-1-2+5-35
D
2016-08-01
ALDRLatham John AChief Scientific OfficerS - Sale+OE$31.19-10,000242,200-4%-$311,948-1-2+5-35
DM
2016-07-26
ALDRLatham John AChief Scientific OfficerS - Sale+OE$30.14-10,000242,200-4%-$301,415+5+3+4-35
D
2016-07-25
ALDRSchatzman Randall CPres, CEOS - Sale+OE$28.08-10,000114,768-8%-$280,8050-2+2-35
2016-06-13
ALDRLitton Mark JamesChief Business OfficerS - Sale$28.94-6,000102,567-6%-$173,664-1-11-10-23
D
2016-06-03
ALDRSmith Jeffrey T LSVP Translational MedicineS - Sale+OE$30.20-16,0900-100%-$485,933-2-7-16-26
D
2016-06-01
ALDRSchatzman Randall CPres, CEOS - Sale+OE$29.65-10,000114,768-8%-$296,544+70-11-19
D
2016-06-01
ALDRLatham John AChief Scientific OfficerS - Sale+OE$30.02-10,000242,200-4%-$300,216+70-11-19
DM
2016-05-27
ALDRLatham John AChief Scientific OfficerS - Sale+OE$30.04-40,000242,200-14%-$1,201,619+6+3-19-21
DM
2016-05-27
ALDRLitton Mark JamesChief Business OfficerS - Sale+OE$30.05-25,000164,567-13%-$751,259+6+3-19-21
DM
2016-05-20
ALDRSchatzman Randall CPres, CEOS - Sale+OE$28.02-10,000112,947-8%-$280,175-2+6-11+1
DM
2016-04-14
ALDRSchatzman Randall CPres, CEOS - Sale+OE$28.07-30,000112,947-21%-$841,967-2+3-9+1
D
2016-01-04
ALDRLitton Mark JamesChief Business OfficerS - Sale+OE$31.40-25,000163,718-13%-$784,951-4-9-24-17
D
2016-01-04
ALDRLatham John AChief Scientific OfficerS - Sale+OE$31.41-10,000241,726-4%-$314,137-4-9-24-17
D
2016-01-04
ALDRSchatzman Randall CPres, CEOS - Sale+OE$31.47-10,000111,579-8%-$314,747-4-9-24-17
D
2015-12-01
ALDRSmith Jeffrey T LSVP Translational MedicineS - Sale+OE$37.24-4,2720-100%-$159,104+1-4-11-17
D
2015-12-01
ALDRLatham John AChief Scientific OfficerS - Sale+OE$37.24-4,550241,726-2%-$169,452+1-4-11-17
D
2015-12-01
ALDRSchatzman Randall CPres, CEOS - Sale+OE$37.24-10,000111,579-8%-$372,431+1-4-11-17
2015-11-30
ALDRDow Stephen MDirS - Sale$37.11-88282,1900%-$3,266-4-6-12-14

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top